Lite Strategy, Inc. — Director's Dealing 2019

Jul 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2019-07-01

Reporting Person: HOWSON TAMAR D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-01	Stock Option (Right to Buy)	$2.52	A	60000	Acquired	2029-07-01	Common Stock (60000)	Direct

Footnotes

F1: 20,000 options will vest in equal monthly installments over thirty-six months, and 40,000 of the options will vest in equal monthly installments over twelve months.